Immatics N.V.
Immatics N.V. (IMTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IMTX · as of Sep 30, 2025
Ownership Breakdown
65
Institutional Holders
▼ 8 vs Q2
$787.24M
Total Inst. Value
▲ $286.34M vs Q2
134.10M
Shares Outstanding
freeFloat 83.67%
92.43M
13F Shares Held
▼ 671,658 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IMTX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. biological products, (no diagnostic substances) | 19.38M | 15.95% | 15.95% | $165.15B | Nov 14, 2025 | ▲ 1.05M |
BAKER BROS. ADVISORS LP biological products, (no diagnostic substances) | 12.09M | 9.95% | 9.95% | $103.04B | Nov 14, 2025 | ▲ 1.93M |
SUVRETTA CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 12.03M | 9.90% | 9.90% | $102.50B | Nov 14, 2025 | — held |
PERCEPTIVE ADVISORS LLC biological products, (no diagnostic substances) | 9.38M | 7.72% | 7.72% | $79.95B | Nov 14, 2025 | — held |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 8.82M | 7.25% | 7.25% | $75.11B | Nov 14, 2025 | ▲ 1.85M |
VESTAL POINT CAPITAL, LP biological products, (no diagnostic substances) | 6.35M | 5.22% | 5.22% | $54.10B | Nov 14, 2025 | ▲ 100.0K |
TORONTO DOMINION BANK biological products, (no diagnostic substances) | 5.12M | 4.21% | 4.21% | $43.64B | Nov 14, 2025 | ▲ 2.21M |
SOFINNOVA INVESTMENTS, INC. biological products, (no diagnostic substances) | 2.23M | 1.83% | 1.83% | $18.98B | Nov 14, 2025 | ▼ 12.7K |
MORGAN STANLEY biological products, (no diagnostic substances) | 2.21M | 1.81% | 1.81% | $18.79B | May 27, 2026 | ▼ 598.8K |
WOODLINE PARTNERS LP biological products, (no diagnostic substances) | 1.84M | 1.52% | 1.52% | $15.69B | Nov 14, 2025 | ▼ 2.04M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
14
Increased
+8.35M shares7
New Positions
first time holders17
Decreased
−8.27M shares0
Sold Out
fully exitedNet shares change (top 50)
+81.7K
+8.35M / −8.27M
Net new holders
+4
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IMTX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Immatics N.V. (IMTX) is primarily owned by institutional investors, who hold approximately 68.9% of total shares outstanding. Company insiders own approximately 16.33%, while retail and public investors account for the remaining 14.74%.
The largest institutional shareholder of Immatics N.V. is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., holding approximately 19.38 million shares — equal to 15.95% of outstanding shares — as of September 30, 2025.
A total of 65 institutional investors currently hold IMTX stock, with a combined institutional value of approximately $787,236,009 as of the most recent 13F filing period.
Frequently asked questions
IMTX ownershipImmatics N.V. (IMTX) is primarily owned by institutional investors, who hold approximately 68.9% of shares. The largest shareholder is T. ROWE PRICE INVESTMENT MANAGEMENT, INC. with a 15.95% stake. Company insiders hold 16.33%. Data sourced from SEC Form 13F as of September 30, 2025.